« Back to Record
Citation APA

Hadji, P., Baber, R. J., Roodman, G. D., Cooper, C., Langdahl, B., Palacios, S., Kanis, J. A., Al-Daghri, N., Nogues, X., Eriksen, E. F., Kurth, A., Aapro, M., Rizzoli, R., Coleman, R., Body, J.-J., Gnant, M., Brandi, M. L., Reginster, J.-Y., Zillikens, M. C. C. M., Glüer, C. C., & De Villiers, T. (2017). Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO IMS, and SIOG. Journal of Bone Oncology, 7, 1-12. doi:10.1016/j.jbo.2017.03.001


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/253186

Hadji, P., Baber, R. J., Roodman, G. D., Cooper, C., Langdahl, B., Palacios, S., Kanis, J. A., Al-Daghri, N., Nogues, X., Eriksen, E. F., Kurth, A., Aapro, M., Rizzoli, R., Coleman, R., Body, J.-J., Gnant, M., Brandi, M. L., Reginster, J.-Y., Zillikens, M. C. C. M., Glüer, C. C., & De Villiers, T. (2017). Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO IMS, and SIOG. Journal of Bone Oncology, 7, 1-12. doi:10.1016/j.jbo.2017.03.001